Lai C, Ranpura V, Wu C, et al. Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab. Blood Adv. 2019;3(7):980-983.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2019
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560351/
https://www.ncbi.nlm.nih.gov/pubmed/31160296
http://dx.doi.org/10.1182/bloodadvances.2019000319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560351/
https://www.ncbi.nlm.nih.gov/pubmed/31160296
http://dx.doi.org/10.1182/bloodadvances.2019000319

Ejemplares similares